Bay Area biotech company Synthego, raised $392M, forced into bankruptcy

by randycupertinoon 5/19/2025, 10:59:02 PM with 2 comments
  • by duxupon 5/19/2025, 11:45:25 PM

    Biotech seems to historically require a lot of iterations / failures before breakthroughs happen.

    I'm not sure the typical VC "startup" type expectations / speed really lends itself to that kind of business.

  • by hoseyoron 5/19/2025, 11:35:24 PM

    I wonder if that was private lending/credit. There seems to be a huge issue building in that unregulated space.